Dr. Lemaitre is interested in new modifiable lipidomic biomarkers that may predict diabetes incidence and cardiovascular complications, with the goal of novel interventions in high risk populations. She is also interested in reducing the burden of aging and currently studies how changes in circulating fatty acids, biomarkers of diet and metabolism, may relate to cardiovascular disease and other aging outcomes in older adults.